Free Trial

Northwest Biotherapeutics (NWBO) SEC Filings & 10K Form

Northwest Biotherapeutics logo
$0.29 0.00 (0.00%)
(As of 11/14/2024 ET)

Recent Northwest Biotherapeutics SEC Filings

DateFilerForm TypeView
11/01/2024
4:24 PM
Northwest Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:30 PM
BOYNTON ALTON L (Reporting)
Northwest Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
9:42 AM
Northwest Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
6:49 PM
MALIK NAVID (Reporting)
Northwest Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:44 PM
Northwest Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
4:25 PM
Northwest Biotherapeutics (Filer)
Form DEFA14A
06/03/2024
4:22 PM
Northwest Biotherapeutics (Filer)
Form DEF 14A
05/10/2024
4:04 PM
Northwest Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2024
3:39 PM
Northwest Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
3:30 PM
Northwest Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
3:30 PM
Northwest Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2023
7:31 PM
MALIK NAVID (Reporting)
Northwest Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
4:11 PM
Northwest Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:NWBO) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners